Company: ABBV
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001104659-25-013467
Chunk: 0

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.  

On February 13, 2025, the Board of Directors
(the “ Board”) of AbbVie Inc. (the “ Company”) unanimously elected Robert A. Michael to succeed Richard A. Gonzalez
as the Company’s Chairman, effective July 1, 2025. Mr. Gonzalez, who has served as Chairman since the Company’s
formation in 2013, will retire from the Board, effective July 1, 2025. Mr. Michael is the Company’s current Chief Executive
Officer, as well as a director on the Board.

On February 13,
2025, Glenn F. Tilton informed the Company of his decision to retire as a director, effective July 1, 2025.